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Several studies have analyzed the relationship between 
androgenetic alopecia and cardiovascular disease (main-
ly heart disease). However few studies have analyzed li-
pid values in men and women separately. This case-con-
trol study included 300 patients consecutively admitted 
to an outpatient clinic, 150 with early onset androgenetic 
alopecia (80 males and 70 females) and 150 controls (80 
males and 70 females) with other skin diseases. Female 
patients with androgenic alopecia showed significant hig-
her triglycerides values (123.8 vs 89.43 mg/dl, p = 0.006), 
total cholesterol values (196.1 vs 182.3 mg/dl, p = 0.014), 
LDL-C values (114.1 vs 98.8 mg/dl, p = 0.0006) and lower 
HDL-C values (56.8 vs 67.7 mg/dl, p <0.0001) versus con-
trols respectively. Men with androgenic alopecia showed 
significant higher triglycerides values (159.7 vs 128.7 mg/
dl, p = 0.04) total cholesterol values (198.3 vs 181.4 mg/dl, 
p = 0.006) and LDL-C values (124.3 vs 106.2, p = 0.0013) 
versus non-alopecic men. A higher prevalence of dyslipi-
demia in women and men with androgenic alopecia has 
been found. The elevated lipid values in these patients 
may contribute, alongside other mechanisms, to the 
development of cardiovascular disease in patient with 
androgenic alopecia. Key words: male and female andro-
genetic alopecia; cardiovascular risk factors; lipid  levels; 
body mass index; weight.
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Androgenic alopecia (AGA) is the most common type of 
alopecia in both men and women, but its prevalence and 
pathogenic mechanisms have been investigated mainly in 
men. That male AGA could be a risk factor for coronary 
heart disease (CHD) was first suggested by Cotton et al. 
(1). Some subsequent studies, almost all conducted in 
male patients, appear to support this association (2–4). 
Only a few studies have analysed the relationship bet-
ween AGA and CHD in women (5–6). Mansouri et al. 
(5) support the hypothesis that AGA is associated with 
CHD in women under the age of 55 years, according to 
angiographic studies. 
The mechanism of the association of CHD and AGA has 
not been elucidated. The relationship between lipid pro-
file and CHD has been analysed in several studies (7); ho-
wever, few papers have analysed lipid values in men and 
women with AGA, which was the objective of this study.
SUBJECTS AND METHODS
Subjects
This case-control study included 300 patients, 150 with AGA 
(80 males and 70 females) and 150 controls (80 males and 70 
females) consecutively admitted to the outpatient clinic (Der-
matology Department, San Cecilio Hospital, Granada, Spain). 
The control group presented skin diseases other than alopecia. 
Diagnosis of AGA was based on family history and clinical 
findings, including: early age of onset (< 35 years), pattern of 
increased hair thinning on frontal/parietal scalp with greater hair 
density on occipital scalp for males; retention of frontal hairline 
(in females); and the presence of miniaturized hairs and diver-
sity of hair diameter (by dermoscopy). Detailed study of the 
consumption of drugs, iron intake and thyroid metabolism ruled 
out other causes of alopecia. The degree of AGA was determi-
ned by application of Ludwig scales (II–III) and Ebling scales 
(III–V). Inclusion criteria were: men and women; aged 35–60 
years; presence of early-onset AGA (age < 35 years) with Ebling 
degree III or above for males (vertex and frontal alopecia); and 
Ludwig degree II or above for females; and signing of informed 
consent to study participation. Exclusion criteria were: receipt 
of hormone replacement therapy with testosterone or corticoids 
for > 1 month (chronic corticoid therapy). Inclusion criteria 
for controls were: males or females with other dermatological 
diseases (mainly naevi, seborrhoeic keratosis, actinic keratosis 
and basal cell carcinoma); aged 35–60 years; and signing of 
informed consent to study participation. Exclusion criteria were 
as described above and the presence of AGA.
Clinical parameters and measurements of lipid levels
Serum total cholesterol (C), triglycerides, high-density lipopro-
tein (HDL)-C and low-density lipoprotein (LDL)-C levels were 
studied in samples drawn between 08.00 h and 09.00 h after a 
12-h fasting period. Also, total-C/HDL-C and LDL-C/HDL-C 
ratios were calculated. Data were also gathered on age, weight, 
height and body mass index (BMI = kg/m2) smoking, alcohol 
consumption, sedentarism, personal or family history of cardio-
vascular disease. Dyslipidaemia was diagnosed if triglycerides 
were > 150 mg/dl, total C was > 200 mg/dl or LDL-C was > 130 
mg/dl, or if treatment for dyslipidaemia was ongoing.
Statistical analyses
Statistical analyses were performed with the SPSS/PC software 
(Version 15.0 for windows SPSS Inc, Chicago, IL, USA). 
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Student’s t-test was used to compare mean values of quantitative 
variables, and the Levene test to study the variance. Qualita-
tive variables were analysed with χ2 test. Correlations among 
variables were studied using the Pearson’s coefficient. p ≤ 0.05 
was considered significant in all analyses.
rESULTS
A total of 150 Caucasian patients with AGA were stu-
died (70 women: 58% II Ludwig degree and 42% III, 
and 80 men: 29% Ebling degree III, 41% IV and 30% 
V). Mean age was 47.7 years (SD 9.3) in the AGA pa-
tient group and 46.6 years (SD 8.7) in the sex-matched 
control group (p = 0.31). Mean time since alopecia 
onset was 16.7 years (16.2 years for women and 17.1 
years for men; p = 0.22). No significant differences 
were found between AGA patients and controls with 
respect to tobacco or alcohol consumption, sedentarism, 
personal or familiar history of CHD. No AGA patient 
or control had family hyperlipidaemia or treatment for 
hyperlipidaemia. 
Mean age, weight, height and BMI values are sum-
marized in Table I for men and women with AGA and 
controls. Men with AGA presented higher significant 
mean weight (84.1 vs. 72.4 kg; p < 0.001) and height 
(173.7 vs. 162.1 m; p < 0.0001) than women with 
AGA. Men with AGA presented higher significant 
values in cholesterol total/HDL-C, LDL-C/HDL-C, 
triglyceridaemia, LDL-C and total cholesterol than 
non alopecic men (Table I). No significant differences 
were observed between Ebling degree (III–V) of AGA 
and lipid parameters.
Women with AGA showed higher significant mean 
values than non-alopecic women for all the parame-
ters (triglyceridaemia, LDL-C, total cholesterol, total 
cholesterol/HDL-C and LDL-C/HDL-C; Table II) and 
lower significant HDL-C than controls. No significant 
differences were observed between Ludwig degree 
(II–III) of AGA in lipid parameters. Men and women 
with AGA presented significantly higher prevalence of 
dyslipidaemia than controls (Table II).
Comparing lipid profile in men and women with AGA, 
we found significant differences in HDL-C, higher for 
alopecic women (48.7 vs. 56.8 mg/dl; p = 0.0009). Men 
with AGA presented significantly higher triglyceridemia 
mean values (159.7 vs. 123.8 mg/dl; p = 0.01), LDL-C 
values (124.3 vs. 114.1 mg/dl; p = 0.04), total choles-
terol/HDL-C (4.07 vs. 3.45; p = 0.0012) and LDL-C/
HDL-C (2.55 vs. 2.1; p = 0.005) than women with AGA. 
There was no significant correlation between all these 
lipids parameters and weight between men and women 
with AGA except for HDL-C in alopecic men (r = –0.48, 
p < 0.001).
DISCUSSION
This study found significantly higher lipid levels in men 
and women with AGA than healthy controls. 
Sadighha et al. (8) studied the lipid profile of men 
with AGA, and found significantly higher levels of 
triglyceride and total cholesterol/HDL-cholesterol ratio 
in men with AGA and significantly lower HDL-C va-
lues. However, in our study we did not find significant 
differences in HDL-C values between men with AGA 
and the control group. Guzzo et al. (9) evaluated lipid 
levels in men with Ebling degree III compared with 
randomly obtained serum lipid profiles of age-matched 
men referring to the reference laboratory. Although no 
statistically significant difference was measured in lipid 
indices between AGA patients and controls, their finding 
Table I. Mean (SD) values for biometrics and lipid levels age in men and women with androgenic alopecia (AGA) and their respectively 













Age (years) 47.1 (8.4) 45.3 (9.2) 0.19 48.2 (9.1) 47.9 (8.1) 0.83
Weight (kg) 84.1 (13.4) 82.2 (10.8) 0.32 72.4 (13.7) 68.9 (13.1) 0.12
Height (cm) 173.7 (7.9) 174.8 (8.1) 0.38 162.1 (6.3) 163.7 (7.2) 0.16
BMI (kg/m2) 27.87 (4.3) 26.95 (3.9) 0.15 27.6 (5.9) 25.9 (5.6) 0.082
Triglycerides (mg/dl) 159.7 (98) 128.7 (97.7) 0.04 123.8 (82.4) 89.43 (63.9) 0.0067
HDL-C (mg/dl) 48.7 (14.2) 48.9 (15.2) 0.93 56.8 (14.7) 67.7(14.1) <0.0001
LDL-C (mg/dl) 124.3 (34) 106.2 (35.7) 0.0013 114.1 (27.3) 98.8 (24.1) 0.0006
Total cholesterol (mg/dl) 198.3(37.2) 181.4 (39.8) 0.0062 196.1 (33.6) 182.3 (32.1) 0.014
Total cholesterol/HDL 4.07 (1.1) 3.70 (1.2) 0.043 3.45 (1.2) 2.69 (0.64) <0.0001
LDL-C/HDL-C 2.55(0.95) 2.17(0.97) 0.013 2.1 (1) 1.45 (0.4) <0.0001
LDL-C: low-density lipoprotein-cholesterol; HDL-C: high-density lipoprotein-cholesterol; BMI: body mass index.
Table II. Prevalence of dyslipidaemia in men and women with 
androgenic alopecia (AGA) and their respectively controls. p-values 





(p-value) Or (95% CI)
Men (n = 80) AGA 66.2 < 0.0001 4.58 (2.35–8.91)
No AGA 30
Women (n = 70) AGA 55.7 0.0006 3.63 (1.77–7.42)
No AGA 25.7
OR: odds ratio; CI: confidence interval.
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is questioned because of confounding factors affecting 
serum lipid profiles (secondary hyperlipidaemia and 
familial hyperlipidaemia) were ignored.
Few studies have analysed the relationship between 
AGA in women and cardiovascular disease. Matilai-
nen et al. (10) support the hypothesis that women with 
some markers of insulin resistance have significantly 
increased risk for female AGA, but they did not find 
significant differences in lipid profiles. Giltay et al. 
(11) analysed 81 female-to-male transsexual subjects 
treated with testosterone esters and 38.3% developed 
AGA; however, no differences in lipid values or weight 
were found.
The pathogenetic mechanisms of atherosclerosis are 
quite well known, but the pathogenetic link between 
alopecia and atherosclerosis is not clear (12, 13). Higher 
cholesterol- and trigyceride-levels participate along 
with other mechanisms initiating atheromatous plaque. 
HDL-C on the other hand protects the vascular wall 
from aggressive factors (endothelial adhesion, migration 
of monocytes, etc.) and facilitates the reverse transport 
of cholesterol. The unfavourable lipid profile in men 
and women with AGA could explain its association with 
CHD. In addition, Matilainen et al. (13) found higher 
LDL-C and triglycerides in men with AGA in patients 
who had undergone coronary artery bypass graft or 
percutaneous transluminal coronary angioplasty.
Increased LDL-cholesterol/HDL-cholesterol ratio has 
already been considered a sensitive predictor for CHD 
in men, and total cholesterol/HDL-C ratio has been 
found to be an even better predictive metabolic index 
for CHD risk in a large study (14). Sharrett et al. (15) 
stated that high levels of triglycerides and low levels of 
HDL-C are associated with the transition from atheroma 
to atherothrombosis. Therefore, control of these two 
cardiovascular risk factors is essential in patients with 
subclinical disease.
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